Hong Kong SAR China · Investor

Lilly Asia Ventures

Last cheque observed Sep 2026; 118 cheques on record.

Email

Deploying nowNew fund, Mar 2015VC firm

Series BSeries AVentureBiotechnologyHealth Care

Deploying now
89%of best year24cheques in 12 months, 118 on record
Since the last cheque60days00hrs00min00sec
Median round$62MRounds led0 of 118Sole investor16 roundsMostly inUnited States, 80%
Pitch Lilly Asia Ventures

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. Tell us which if you know.

Lilly Asia Ventures highlights

  1. 01

    24 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 59% of its rounds

  3. 03

    Sole investor in 16 rounds, median $30M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth Care
Based in
Hong Kong SAR China
Cold pitches
Not stated

The record

Every round we can evidence, newest first118 appearances

  1. 2026

    16 rounds

  2. Sept
    Cornerstone RoboticsVenture · HK$700MWith 3 others
  3. Sept
    Connexus TherapeuticsSeries A · HK$5.0MWith 1 other
  4. Sept
    Tempest TherapeuticsUS$2.5MWith 4 others
  5. Aug
    Khartis TherapeuticsSeries B · US · Ventureburn$50MWith 5 others
  6. Jun
    Legend BiotechUS$226MWith 2 others
  7. May
    ArriVentUS$250MWith 4 others
  8. Mar
    Excalipoint TherapeticsSeed · HK$28MWith 3 others
  9. Mar
    InhibrxDebt · US$75MWith 4 others
  10. Feb
    GluBio TherapeuticsVenture$30MWith 4 others
  11. Feb
    QuantX BiosciencesSeries B · US$85MWith 3 others
  12. Jan
    XellSmartVentureUndisclosedWith 3 others
  13. Jan
    Precede BiosciencesSeries B · US$64MWith 2 others
  14. Jan
    NeuShen TherapeuticsVentureUndisclosedSole investor
  15. Jan
    Caldera TherapeuticsSeries A · US$38MWith 4 others
  16. Jan
    AlumisUS$345MWith 6 others
  17. Jan
    Just - Evotec BiologicsVenture · USUndisclosedWith 3 others
  18. 2025

    24 rounds

  19. Dec
    SyneronSeries A$100MWith 2 others
  20. Dec
    Akura MedicalSeries C · US$53MWith 1 other
  21. Dec
    SciNeuroVenture · US$53MWith 3 others
  22. Dec
    Structure TherapeuticsUS$748MWith 6 others
  23. Dec
    Terns PharmaceuticalsUS$650MWith 3 others
  24. Nov
    Sonoma BiotherapeuticsGrant · US$300KWith 4 others
  25. Nov
    Fine VisionVentureUndisclosedSole investor
  26. Nov
    NextCureUS$22MWith 4 others
  27. Oct
    Starna TherapeuticsSeries B$42MWith 3 others
  28. Sept
    Ronovo SurgicalSeries D$67MWith 2 others
  29. Jul
    ArriVentUS$75MWith 4 others
  30. Jun
    OTR TherapeuticsSeries A$100MSole investor
  31. Jun
    Kelun Biotech$250MWith 2 others
  32. Apr
    Heyuan Medical DevicesSeries A$14MSole investor
  33. Apr
    Dizal Pharma$246MWith 1 other
  34. Apr
    EnchannelSeries B$82MSole investor
  35. Apr
    Novlead BiotechVentureUndisclosedWith 2 others
  36. Mar
    Rona TherapeuticsSeries B$25MSole investor
  37. Feb
    ADARx PharmaceuticalsVenture · USUndisclosedWith 6 others
  38. Jan
    Cornerstone RoboticsSeries C · HK · Alpha JWC Ventures$70MWith 8 others
  39. Jan
    Alebund PharmaceuticalsSeries C$75MWith 2 others
  40. Jan
    InhibrxDebt · US$150MWith 4 others
  41. Jan
    Verdiva BioSeries A · GB$411MWith 4 others
  42. Jan
    Timberlyne TherapeuticsSeries A · US$180MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

YSYi ShiSole DirectoriFiling they signed

We also hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

3+funds on filenumbered funds in its name

Who they invest alongside

The investors most often in the same rounds as Lilly Asia Ventures. A count of rooms they were both in, not a relationship either has claimed.

HSGVC firm15rounds togetherOrbiMedPrivate equity14rounds togetherQiming Venture PartnersVC firm12rounds togetherHill House CapitalFamily office11rounds togetherVivo CapitalPrivate equity10rounds togetherCormorant Asset ManagementPrivate equity9rounds togetherARCH Venture PartnersVC firm8rounds togetherMatrix Partners ChinaVC firm8rounds togetherRA Capital ManagementPrivate equity7rounds togetherForesite CapitalPrivate equity6rounds togetherGeneral AtlanticPrivate equity5rounds togetherLegend CapitalVC firm5rounds together

Recently backed

The latest companies Lilly Asia Ventures put money into.

Cornerstone Robotics$700M · Sept 2026Tempest Therapeutics$2.5M · Sept 2026Legend Biotech$226M · Jun 2026ArriVent$250M · May 2026Excalipoint Therapetics$28M · Mar 2026QuantX Biosciences$85M · Feb 2026

Quick answers about Lilly Asia Ventures

What does Lilly Asia Ventures invest in?

Lilly Asia Ventures invests most often at Series B and Series A (59% of the rounds on record), in sectors such as Biotechnology and Health Care.

How active is Lilly Asia Ventures?

118 investments on record, 24 of them in the last 12 months. The most recent was in Sept 2026.

What has Lilly Asia Ventures invested in recently?

Its most recent investments on record: Cornerstone Robotics (Venture, Sept 2026), Connexus Therapeutics (Series A, Sept 2026) and Tempest Therapeutics (Undisclosed round, Sept 2026).

How big are Lilly Asia Ventures's cheques?

The median round it joins is $62M.

Does Lilly Asia Ventures lead rounds?

Rarely, if at all: none of its 118 investments on record names it as the lead.

Where does Lilly Asia Ventures invest?

Most of the companies it backs are in the United States (80%) and Hong Kong SAR China (16%).

Is Lilly Asia Ventures investing now?

Yes: it is actively investing, with 24 investments in the last 12 months.

Who does Lilly Asia Ventures invest alongside?

Most often HSG (15 rounds together), OrbiMed (14 rounds together) and Qiming Venture Partners (12 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it